These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 30953467)

  • 1. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR
    J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
    Buisman FE; Grünhagen DJ; Homs MYV; Grootscholten C; Filipe WF; Kemeny NE; Cercek A; D'Angelica MI; Donswijk ML; van Doorn L; Emmering J; Jarnagin WR; Kingham TP; Klompenhouwer EG; Kok NFM; Kuiper MC; Moelker A; Prevoo W; Versleijen MWJ; Verhoef C; Kuhlmann KFD; Groot Koerkamp B
    Ann Surg Oncol; 2019 Dec; 26(13):4599-4607. PubMed ID: 31641947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
    Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
    Buisman FE; Galjart B; van der Stok EP; Kemeny NE; Balachandran VP; Boerner T; Cercek A; Grünhagen DJ; Jarnagin WR; Kingham TP; Verhoef C; Koerkamp BG; D'Angelica MI
    HPB (Oxford); 2020 Sep; 22(9):1271-1279. PubMed ID: 31889627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
    Shapera E; Ross S; Pattilachan T; Christodoulou M; Sucandy I
    Ann Surg Oncol; 2024 Jul; 31(7):4449-4451. PubMed ID: 38632219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI
    Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
    J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.
    Kemeny MM; Adak S; Gray B; Macdonald JS; Smith T; Lipsitz S; Sigurdson ER; O'Dwyer PJ; Benson AB
    J Clin Oncol; 2002 Mar; 20(6):1499-505. PubMed ID: 11896097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage regional therapy using hepatic artery infusion pump in unresectable chemotherapy resistant colorectal liver metastases.
    O'Leary MP; Wang C; Sandhu J; Malhotra GK; Thornblade LW; Lau C; Melstrom LG; Fong Y; Singh G; Fakih MG
    Am J Surg; 2022 Jun; 223(6):1151-1156. PubMed ID: 34696847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
    Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
    BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
    Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
    Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    Walker BS; Billingsley KG; Sutton TL; Kolbeck KJ; Korngold EK; Nabavizadeh N; Dewey EN; Herzig DO; Lopez CD; Mayo SC
    J Surg Oncol; 2022 Sep; 126(3):513-522. PubMed ID: 35522249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.